Hepsin promotes prostate cancer progression and metastasis

Cancer Cell

Volumn 6, Issue 2, 2004, Pages 185-195

  Klezovitch, Olga ^a   Chevillet, John ^a,b   Mirosevich, Janni ^c   Roberts, Richard L ^c   Matusik, Robert J ^c   Vasioukhin, Valeri ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; SERINE PROTEINASE; SERINE PROTEINASE HEPSIN; UNCLASSIFIED DRUG; HEPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BONE METASTASIS; CANCER GROWTH; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME REGULATION; GENE OVEREXPRESSION; LIVER METASTASIS; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ANIMAL; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE; PROSTATE TUMOR; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALIA;

ANIMALS; APOPTOSIS; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL DIVISION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; PROSTATE; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES;

EID: 5144225237     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.07.008     Document Type: Article

References (40)

1. Abate-Shen C., Shen M.M. Molecular genetics of prostate cancer. Genes Dev. 14:2000;2410-2434
2. Bernards R., Weinberg R.A. A progression puzzle. Nature. 418:2002;823
3. Bonkhoff H. Analytical molecular pathology of epithelial-stromal interactions in the normal and neoplastic prostate. Anal. Quant. Cytol. Histol. 20:1998;437-442
4. Chang C., Werb Z. The many faces of metalloproteases. Cell growth, invasion, angiogenesis and metastasis Trends Cell Biol. 11:2001;S37-S43
5. Chen Z., Fan Z., McNeal J.E., Nolley R., Caldwell M.C., Mahadevappa M., Zhang Z., Warrington J.A., Stamey T.A. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J. Urol. 169:2003;1316-1319
6. Davis T.L., Cress A.E., Dalkin B.L., Nagle R.B. Unique expression pattern of the α6β4 integrin and laminin-5 in human prostate carcinoma. Prostate. 46:2001;240-248
7. Del Rosso M., Fibbi G., Pucci M., D'Alessio S., Del Rosso A., Magnelli L., Chiarugi V. Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin. Exp. Metastasis. 19:2002;193-207
8. Dhanasekaran S.M., Barrette T.R., Ghosh D., Shah R., Varambally S., Kurachi K., Pienta K.J., Rubin M.A., Chinnaiyan A.M. Delineation of prognostic biomarkers in prostate cancer. Nature. 412:2001;822-826
9. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:2002;161-174
10. Ernst T., Hergenhahn M., Kenzelmann M., Cohen C.D., Bonrouhi M., Weninger A., Klaren R., Grone E.F., Wiesel M., Gudemann C., et al. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma. A gene expression analysis on total and microdissected prostate tissue Am. J. Pathol. 160:2002;2169-2180
11. Fijnvandraat A.C., De Boer P.A., Deprez R.H., Moorman A.F. Non-radioactive in situ detection of mRNA in ES cell-derived cardiomyocytes and in the developing heart. Microsc. Res. Tech. 58:2002;387-394
12. Hooper J.D., Clements J.A., Quigley J.P., Antalis T.M. Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J. Biol. Chem. 276:2001;857-860
13. Ihara S., Miyoshi E., Ko J.H., Murata K., Nakahara S., Honke K., Dickson R.B., Lin C.Y., Taniguchi N. Prometastatic effect of N- acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J. Biol. Chem. 277:2002;16960-16967
14. Kasper S., Sheppard P.C., Yan Y., Pettigrew N., Borowsky A.D., Prins G.S., Dodd J.G., Duckworth M.L., Matusik R.J. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice. a model for prostate cancer Lab. Invest. 78:1998;319-333
15. Kazama Y., Hamamoto T., Foster D.C., Kisiel W. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J. Biol. Chem. 270:1995;66-72
16. Lin B., Ferguson C., White J.T., Wang S., Vessella R., True L.D., Hood L., Nelson P.S. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res. 59:1999;4180-4184
17. Luo J., Duggan D.J., Chen Y., Sauvageot J., Ewing C.M., Bittner M.L., Trent J.M., Isaacs W.B. Human prostate cancer and benign prostatic hyperplasia. Molecular dissection by gene expression profiling Cancer Res. 61:2001;4683-4688
18. Magee J.A., Araki T., Patil S., Ehrig T., True L., Humphrey P.A., Catalona W.J., Watson M.A., Milbrandt J. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 61:2001;5692-5696
19. Murant S.J., Handley J., Stower M., Reid N., Cussenot O., Maitland N.J. Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. Eur. J. Cancer. 33:1997;263-271
20. Nagle R.B., Hao J., Knox J.D., Dalkin B.L., Clark V., Cress A.E. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am. J. Pathol. 146:1995;1498-1507
21. Netzel-Arnett S., Hooper J.D., Szabo R., Madison E.L., Quigley J.P., Bugge T.H., Antalis T.M. Membrane anchored serine proteases. A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer Cancer Metastasis Rev. 22:2003;237-258
22. Robinson V.L., Kauffman E.C., Sokoloff M.H., Rinker-Schaeffer C.W. The basic biology of metastasis. Cancer Treat. Res. 118:2004;1-21
23. Ryan M.C., Lee K., Miyashita Y., Carter W.G. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J. Cell Biol. 145:1999;1309-1323
24. Sambrook, J., and Russell, D.W. (2001). Molecular cloning: A laboratory manual, 3rd ed. (Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press).
25. Shappell S.B., Thomas G.V., Roberts R.L., Herbert R., Ittmann M.M., Rubin M.A., Humphrey P.A., Sundberg J.P., Rozengurt N., Barrios R., et al. Prostate pathology of genetically engineered mice. Definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee Cancer Res. 64:2004;2270-2305
26. Srikantan V., Valladares M., Rhim J.S., Moul J.W., Srivastava S. HEPSIN inhibits cell growth/invasion in prostate cancer cells. Cancer Res. 62:2002;6812-6816
27. Stamey T.A., Warrington J.A., Caldwell M.C., Chen Z., Fan Z., Mahadevappa M., McNeal J.E., Nolley R., Zhang Z. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J. Urol. 166:2001;2171-2177
28. Stephan C., Yousef G.M., Scorilas A., Jung K., Jung M., Kristiansen G., Hauptmann S., Kishi T., Nakamura T., Loening S.A., Diamandis E.P. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. J. Urol. 171:2004;187-191
29. Takeuchi T., Shuman M.A., Craik C.S. Reverse biochemistry. Use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue Proc. Natl. Acad. Sci. USA. 96:1999;11054-11061
30. Takeuchi T., Harris J.L., Huang W., Yan K.W., Coughlin S.R., Craik C.S. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275:2000;26333-26342
31. Tanimoto H., Yan Y., Clarke J., Korourian S., Shigemasa K., Parmley T.H., Parham G.P., O'Brien T.J. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res. 57:1997;2884-2887
32. Vasioukhin V., Degenstein L., Wise B., Fuchs E. The magical touch. Genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin Proc. Natl. Acad. Sci. USA. 96:1999;8551-8556
33. Vasioukhin V., Bauer C., Degenstein L., Wise B., Fuchs E. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell. 104:2001;605-617
34. Wallrapp C., Hahnel S., Muller-Pillasch F., Burghardt B., Iwamura T., Ruthenburger M., Lerch M.M., Adler G., Gress T.M. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res. 60:2000;2602-2606
35. Welsh J.B., Sapinoso L.M., Su A.I., Kern S.G., Wang-Rodriguez J., Moskaluk C.A., Frierson H.F. Jr., Hampton G.M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61:2001;5974-5978
36. Werb Z., Vu T.H., Rinkenberger J.L., Coussens L.M. Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS. 107:1999;11-18
37. Wu Q. Type II transmembrane serine proteases. Curr. Top. Dev. Biol. 54:2003;167-206
38. Wu Q., Yu D., Post J., Halks-Miller M., Sadler J.E., Morser J. Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J. Clin. Invest. 101:1998;321-326
39. Yan W., Sheng N., Seto M., Morser J., Wu Q. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J. Biol. Chem. 274:1999;14926-14935
40. Zhang J., Thomas T.Z., Kasper S., Matusik R.J. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology. 141:2000;4698-4710